These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8422738)

  • 1. Awakenings: using a popular movie to teach clinical pharmacology.
    Koren G
    Clin Pharmacol Ther; 1993 Jan; 53(1):3-5. PubMed ID: 8422738
    [No Abstract]   [Full Text] [Related]  

  • 2. Putting clinical pharmacology in context: the use of popular movies.
    Farré M; Bosch F; Roset PN; Baños JE
    J Clin Pharmacol; 2004 Jan; 44(1):30-6. PubMed ID: 14681339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa: rational and irrational pharmacology.
    Nutt JG
    Ann Neurol; 1994 Jul; 36(1):4-5. PubMed ID: 8024259
    [No Abstract]   [Full Text] [Related]  

  • 4. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
    [No Abstract]   [Full Text] [Related]  

  • 5. Did levodopa vs. dopamine agonist trials teach us when and how to start symptomatic therapy?
    Waters C
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S31-3. PubMed ID: 20083002
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Cabergoline versus levodopa monotherapy: a decision analysis.
    Marras C
    Mov Disord; 2004 Jun; 19(6):736. PubMed ID: 15197726
    [No Abstract]   [Full Text] [Related]  

  • 7. Prosodic expression and levodopa in Parkinson's disease.
    Behlau M
    Arq Neuropsiquiatr; 2013 Nov; 71(11):831-2. PubMed ID: 24394865
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parkinson disease. Medical treatment].
    Fénelon G
    Presse Med; 1997 Sep; 26(28):1357-61. PubMed ID: 9365497
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of levodopa on "frontal" signs in Parkinsonism.
    Morel-Maroger A
    Br Med J; 1977 Dec; 2(6101):1543-4. PubMed ID: 589336
    [No Abstract]   [Full Text] [Related]  

  • 10. A curricular divide: basic pharmacology vs. clinical pharmacology.
    Gilliland WR; Waechter DM
    Clin Pharmacol Ther; 2011 Jan; 89(1):24-6. PubMed ID: 21170067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.
    Kempster PA; Lees AJ
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1444. PubMed ID: 7964840
    [No Abstract]   [Full Text] [Related]  

  • 12. Levodopa and the progression of Parkinson's disease.
    Walton-Hadlock JL
    N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa therapy in Parkinson's disease.
    Koller WC; Hubble JP
    Neurology; 1990 Oct; 40(10 Suppl 3):suppl 40-7; discussion 47-9. PubMed ID: 2215973
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease.
    Stacy M; Hauser R
    J Neural Transm (Vienna); 2007 Feb; 114(2):211-7. PubMed ID: 16897594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease.
    Mouradian MM; Heuser IJ; Baronti F; Giuffra M; Conant K; Davis TL; Chase TN
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):401-5. PubMed ID: 1865201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of pediatric clinical pharmacology: an international survey of training programs.
    Koren G; Macleod SM
    Clin Pharmacol Ther; 1989 Nov; 46(5):489-93. PubMed ID: 2582705
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa therapy for Parkinson's disease: challenges and future prospects.
    Olanow CW; Lees A; Obeso J
    Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
    [No Abstract]   [Full Text] [Related]  

  • 18. Off and on state assessment of swallowing function in Parkinson's disease.
    Warnecke T; Hamacher C; Oelenberg S; Dziewas R
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546
    [No Abstract]   [Full Text] [Related]  

  • 19. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's disease: disagreements.
    Schulzer M
    Ann Neurol; 1997 Jun; 41(6):833-4. PubMed ID: 9189047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.